Role of gabapentin in the management of alcohol withdrawal and dependence

Annals of Pharmacotherapy

Volumn 49, Issue 8, 2015, Pages 897-906

  Leung, Jonathan G ^a   Hall Flavin, Daniel ^a   Nelson, Sarah ^a   Schmidt, Kristen A ^a   Schak, Kathryn M ^a  

^a MAYO CLINIC   (United States)

Author keywords

Alcohol; Alcohol dependence; Alcohol withdrawal; Anxiety; Cravings; Gabapentin; Mood; Sleep

Indexed keywords

ALCOHOL; CHLORDIAZEPOXIDE; CLOMETHIAZOLE; CLONAZEPAM; DIAZEPAM; GABAPENTIN; GAMMA GLUTAMYLTRANSFERASE; LORAZEPAM; METHADONE; NALTREXONE; PHENOBARBITAL; 4 AMINOBUTYRIC ACID; AMINE; CYCLOHEXANECARBOXYLIC ACID DERIVATIVE;

ALCOHOL CONSUMPTION; ALCOHOL WITHDRAWAL; ALCOHOLISM; ANXIETY; ARTICLE; DAYTIME SOMNOLENCE; DOSE RESPONSE; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG TOLERABILITY; HUMAN; INSOMNIA; LONG TERM CARE; MEDLINE; MONOTHERAPY; MOOD; PRIORITY JOURNAL; PROSPECTIVE STUDY; PUBLICATION; SLEEP; TREATMENT FAILURE; TREATMENT RESPONSE; WITHDRAWAL SYNDROME; DISEASE MANAGEMENT; SUBSTANCE WITHDRAWAL SYNDROME;

ALCOHOLISM; AMINES; CYCLOHEXANECARBOXYLIC ACIDS; DISEASE MANAGEMENT; ETHANOL; GAMMA-AMINOBUTYRIC ACID; HUMANS; PROSPECTIVE STUDIES; SUBSTANCE WITHDRAWAL SYNDROME;

EID: 84943174993     PISSN: 10600280     EISSN: 15426270     Source Type: Journal    
DOI: 10.1177/1060028015585849     Document Type: Article

References (30)

1. Moss HB. The impact of alcohol on society: a brief overview. Soc Work Public Health. 2013;28(3-4):175-177. doi:10.1080/19371918.2013.758987.
2. Bayard M, McIntyre J, Hill KR, Woodside J Jr. Alcohol withdrawal syndrome. Am Fam Physician. 2004;69:1443-1450.
3. Daeppen JB, Gache P, Landry U, et al. Symptom-triggered vs fixed-schedule doses of benzodiazepine for alcohol withdrawal: a randomized treatment trial. Arch Intern Med. 2002;162:1117-1121.
4. American Psychiatric Association. Desk reference to the diagnostic criteria from DSM-5. Choice: Current Reviews for Academic Libraries. http://go.galegroup.com/ps/i.do?id=GALE%7CA393972300&v=2.1&u=mlin_m_tufts&it=r&p=AONE&sw=w&asid=85cf0ae34ec468342a1e20107f79f55c. Accessed April 20, 2015.
5. Mann K. Pharmacotherapy of alcohol dependence: a review of the clinical data. CNS Drugs. 2004;18:485-504.
6. Williams SH. Medications for treating alcohol dependence. Am Fam Physician. 2005;72:1775-1780.
7. Mack A. Examination of the evidence for off-label use of gabapentin. J Manag Care Pharm. 2003;9:559-568.
8. Watson WP, Robinson E, Little HJ. The novel anticonvulsant, gabapentin, protects against both convulsant and anxiogenic aspects of the ethanol withdrawal syndrome. Neuropharmacology. 1997;36:1369-1375.
9. Bailey CP, Molleman A, Little HJ. Comparison of the effects of drugs on hyperexcitability induced in hippocampal slices by withdrawal from chronic ethanol consumption. Br J Pharmacol. 1998;123:215-222. doi:10.1038/sj.bjp.0701596.
10. Clemens KJ, Vendruscolo LF. Anxious to drink: gabapentin normalizes GABAergic transmission in the central amygdala and reduces symptoms of ethanol dependence. J Neurosci. 2008;28:9087-9089. doi:10.1523/JNEUROSCI.2928-08.2008.
11. Beydoun A, Uthman BM, Sackellares JC. Gabapentin: pharmacokinetics, efficacy, and safety. Clin Neuropharmacol. 1995;18:469-481.
12. Caputo F, Bernardi M. Medications acting on the GABA system in the treatment of alcoholic patients. Curr Pharm Des. 2010;16:2118-2125.
13. Schneekloth TD, Biernacka JM, Hall-Flavin DK, et al. Alcohol craving as a predictor of relapse. Am J Addict. 2012;21 (suppl 1):S20-S26. doi:10.1111/j.1521-0391.2012.00297.x.
14. Kolla BP, Mansukhani MP, Schneekloth T. Pharmacological treatment of insomnia in alcohol recovery: a systematic review. Alcohol Alcohol. 2011;46:578-585. doi:10.1093/alcalc/agr073.
15. Bonnet U, Banger M, Leweke FM, et al. Treatment of acute alcohol withdrawal with gabapentin: results from a controlled two-center trial. J Clin Psychopharmacol. 2003;23:514-519. doi:10.1097/01.jcp.0000088905.24613.ad.
16. Bonnet U, Hamzavi-Abedi R, Specka M, Wiltfang J, Lieb B, Scherbaum N. An open trial of gabapentin in acute alcohol withdrawal using an oral loading protocol. Alcohol Alcohol. 2010;45:143-145. doi:10.1093/alcalc/agp085.
17. Myrick H, Malcolm R, Randall PK, et al. A double-blind trial of gabapentin versus lorazepam in the treatment of alcohol withdrawal. Alcohol Clin Exp Res. 2009;33:1582-1588. doi:10.1111/j.1530-0277.2009.00986.x.
18. Mariani JJ, Rosenthal RN, Tross S, Singh P, Anand OP. A randomized, open-label, controlled trial of gabapentin and phenobarbital in the treatment of alcohol withdrawal. Am J Addict. 2006;15:76-84. doi:10.1080/10550490500419110.
19. Stock CJ, Carpenter L, Ying J, Greene T. Gabapentin versus chlordiazepoxide for outpatient alcohol detoxification treatment. Ann Pharmacother. 2013;47:961-969. doi:10.1345/aph.1R751.
20. Brower KJ, Myra Kim H, Strobbe S, Karam-Hage MA, Consens F, Zucker RA. A randomized double-blind pilot trial of gabapentin versus placebo to treat alcohol dependence and comorbid insomnia. Alcohol Clin Exp Res. 2008;32: 1429-1438. doi:10.1111/j.1530-0277.2008.00706.x.
21. Furieri FA, Nakamura-Palacios EM. Gabapentin reduces alcohol consumption and craving: a randomized, double-blind, placebo-controlled trial. J Clin Psychiatry. 2007;68:1691-1700.
22. Mason BJ, Quello S, Goodell V, Shadan F, Kyle M, Begovic A. Gabapentin treatment for alcohol dependence: a randomized clinical trial. JAMA Intern Med. 2014;174:70-77. doi:10.1001/jamainternmed.2013.11950.
23. Anton RF, Myrick H, Baros AM, et al. Efficacy of a combination of flumazenil and gabapentin in the treatment of alcohol dependence: relationship to alcohol withdrawal symptoms. J Clin Psychopharmacol. 2009;29:334-342. Doi: 10.1097/JCP.0b013e3181aba6a4.
24. Anton RF, Myrick H, Wright TM, et al. Gabapentin combined with naltrexone for the treatment of alcohol dependence. Am J Psychiatry. 2011;168:709-717. doi:10.1176/appi.ajp.2011.10101436.
25. Bisaga A, Evans SM. The acute effects of gabapentin in combination with alcohol in heavy drinkers. Drug Alcohol Depend. 2006;83:25-32. doi:10.1016/j.drugalcdep.2005.10.008.
26. Klein-Schwartz W, Shepherd JG, Gorman S, Dahl B. Characterization of gabapentin overdose using a poison center case series. J Toxicol Clin Toxicol. 2003;41:11-15.
27. Wills B, Reynolds P, Chu E, et al. Clinical outcomes in newer anticonvulsant overdose: a poison center observational study. J Med Toxicol. 2014;10:254-260. doi:10.1007/s13181-014-0384-5.
28. Malcolm R, Myrick LH, Veatch LM, Boyle E, Randall PK. Self-reported sleep, sleepiness, and repeated alcohol withdrawals: a randomized, double blind, controlled comparison of lorazepam vs gabapentin. J Clin Sleep Med. 2007;3: 24-32.
29. Pittenger C, Desan PH. Gabapentin abuse, and delirium tremens upon gabapentin withdrawal. J Clin Psychiatry. 2007;68:483-484.
30. Beydoun A, Uthman BM, Sackellares JC. Gabapentin: pharmacokinetics, efficacy, and safety. Clin Neuropharmacol. 1995;18:469-481. doi:10.1097/00002826-199512000- 00001.